Advertisement
Canada markets open in 24 minutes
  • S&P/TSX

    21,871.96
    +64.59 (+0.30%)
     
  • S&P 500

    5,010.60
    +43.37 (+0.87%)
     
  • DOW

    38,239.98
    +253.58 (+0.67%)
     
  • CAD/USD

    0.7301
    +0.0000 (+0.00%)
     
  • CRUDE OIL

    80.99
    -0.91 (-1.11%)
     
  • Bitcoin CAD

    90,638.27
    +19.96 (+0.02%)
     
  • CMC Crypto 200

    1,419.35
    +4.59 (+0.32%)
     
  • GOLD FUTURES

    2,323.70
    -22.70 (-0.97%)
     
  • RUSSELL 2000

    1,967.47
    +19.82 (+1.02%)
     
  • 10-Yr Bond

    4.6420
    +0.0190 (+0.41%)
     
  • NASDAQ futures

    17,420.75
    +70.75 (+0.41%)
     
  • VOLATILITY

    16.55
    -0.39 (-2.30%)
     
  • FTSE

    8,034.32
    +10.45 (+0.13%)
     
  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     
  • CAD/EUR

    0.6842
    -0.0008 (-0.12%)
     

Stocks in play: The Yield Growth Corp.

Announced it has licensed its patent pending proprietary technology for extracting key chemical compounds from hemp to its wholly owned subsidiary Yield Botanicals to establish a CBD extraction business in the U.S. Yield Botanicals is well positioned to capitalize on substantial growth in the CBD market. It's licensed patent pending technology shows early promise of significantly increasing the yield of valuable chemical compounds per kilogram of hemp root input during the extraction process, as tested by an independent lab. Yield Botanicals intends to use the same technology as part of the CBD extraction process to increase the yield of CBD from hemp. It also intends to conduct research and development using the technology to create a water soluble CBD for beverages and to create a CBD nano-emulsion to enhance transdermal bioavailability of topical products. Yield Botanicals also intends to conduct further research regarding a non toxic plant based surfactant it has identified to enable creation of clean CBD products. The Yield Growth Corp. shares BOSS:CNX are trading unchanged at $0.27.